Balyasny Asset Management
IDXX icon

Balyasny Asset Management’s Idexx Laboratories IDXX Stock Holding History

Balyasny Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-700
Closed -$474K – 3182
2025
Q4 		$474K Sell
700
-2,100
-75% -$1.43M ﹤0.01% 2544
2025
Q3 		$1.79M Buy
+2,800
New +$1.7M ﹤0.01% 1855
2015
Q4 		– Sell
-16,000
Closed -$1.19M – 1326
2015
Q3 		$1.19M Buy
+16,000
New +$1.15M 0.01% 718

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Balyasny Asset Management's IDXX Position: Q1 2026 in Review

Balyasny Asset Management increased its Idexx Laboratories (IDXX) stake by 1% in Q1 2026, buying an estimated $8.34K and bringing the position to 1,308 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #2202.

Balyasny Asset Management first reported a position in IDXX in Q2 2015 and has held it in 28 quarters since. The position peaked at $21.2M in Q3 2015. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Balyasny Asset Management held 1,308 shares of Idexx Laboratories worth $735K as of Q1 2026.
  • Balyasny Asset Management bought 13 Idexx Laboratories shares in Q1 2026, an estimated $8.34K.
  • Idexx Laboratories made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2202 holding.
  • Balyasny Asset Management first reported a position in Idexx Laboratories in Q2 2015 and has held it in 28 quarters since.
  • Balyasny Asset Management's Idexx Laboratories position peaked at $21.2M in Q3 2015.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.